Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 11, 2019
Using macropinocytosis for intracellular delivery of therapeutic nucleic acids to tumour cellsArpan S Desai, Morag R Hunter, Alexander N KapustinThe Biochemical Journal|September 22, 2017
VPS18 recruits VPS41 to the human HOPS complex via a RING-RING interactionMorag R Hunter, Edward J Scourfield, Edward Emmott, et al.Journal of Molecular Biology|May 21, 2018
Proteomic and Biochemical Comparison of the Cellular Interaction Partners of Human VPS33A and VPS33BMorag R Hunter, Geoffrey G Hesketh, Tomasz H Benedyk, et al.Neurotoxicology|September 7, 2014
Effects of the Parkinsonian toxin MPP+ on electrophysiological properties of nigral dopaminergic neuronsAndrew G Yee, Sun-Min Lee, Morag R Hunter, et al.Methods in Enzymology|July 29, 2017
Real-Time Measurement of Cannabinoid Receptor-Mediated cAMP SignalingMorag R Hunter, David B Finlay, Christa E Macdonald, et al.British Journal of Pharmacology|May 19, 2017
Gαs signalling of the CB1 receptor and the influence of receptor numberDavid B Finlay, Erin E Cawston, Natasha L Grimsey, et al.Protein Engineering, Design & Selection : PEDS|February 19, 2015
Structural and dynamic properties that govern the stability of an engineered fibronectin type III domainBenjamin T Porebski, Adrian A Nickson, David E Hoke, et al.Small (Weinheim an Der Bergstrasse, Germany)|December 16, 2021
Mechanistic Studies of an Automated Lipid Nanoparticle Reveal Critical Pharmaceutical Properties Associated with Enhanced mRNA Functional Delivery In Vitro and In VivoLili Cui, Morag R Hunter, Silvia Sonzini, et al.Protein Engineering, Design & Selection : PEDS|September 1, 2016
Circumventing the stability-function trade-off in an engineered FN3 domainBenjamin T Porebski, Paul J Conroy, Nyssa Drinkwater, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|June 19, 2022
Lipid-peptide nanocomplexes for mRNA delivery in vitro and in vivoDania Grant-Serroukh, Morag R Hunter, Ruhina Maeshima, et al.Pageof 1